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Background: A high perioperative inspiratory oxygen fraction (FiO2) may reduce the frequency of surgical site
infection. Perioperative atelectasis is caused by absorption, compression and reduced function of surfactant. It is
well accepted, that ventilation with 100% oxygen for only a few minutes is associated with significant formation of
atelectasis. However, it is still not clear if a longer period of 80% oxygen results in more atelectasis compared to a
low FiO2.
Our aim was to assess if a high FiO2 is associated with impaired oxygenation and decreased pulmonary functional
residual capacity (FRC).
Methods: Thirty-five patients scheduled for laparotomy for ovarian cancer were randomized to receive either 30%
oxygen (n = 15) or 80% oxygen (n = 20) during and for 2 h after surgery. The oxygenation index (PaO2/FiO2) was
measured every 30 min during anesthesia and 90 min after extubation. FRC was measured the day before surgery
and 2 h after extubation by a rebreathing method using the inert gas SF6.
Results: Five min after intubation, the median PaO2/FiO2 was 69 kPa [53-71] in the 30%-group vs. 60 kPa [47-69] in
the 80%-group (P= 0.25). At the end of anesthesia, the PaO2/FiO2 was 58 kPa [40-70] vs. 57 kPa [46-67] in the 30%-
and 80%-group, respectively (P= 0.10). The median FRC was 1993 mL [1610-2240] vs. 1875 mL [1545-2048] at
baseline and 1615 mL [1375-2318] vs. 1633 mL [1343-1948] postoperatively in the 30%- and 80%-group, respectively
(P= 0.70).
Conclusion: We found no significant difference in oxygenation index or functional residual capacity between
patients given 80% and 30% oxygen for a period of approximately 5 hours.
Trial registration: ClinicalTrials.gov Identifier: NCT00637936.
Keywords: Pulmonary gas exchange, Pulmonary atelectasis, Functional residual capacity, Pulmonary function,
Anesthesia, General, Oxygen, Partial pressure, Surgery, GynaecologicalBackground
Atelectasis is a common perioperative complication [1].
It is observed in more than 90% of all anesthesitized
patients with an average of 3-4% collapsed lung area and
10-15% collapsed lung tissue.
Main mechanisms underlying the atelectasis formation
are compression, loss of surfactant or impared surfactant* Correspondence: akstaehr1@hotmail.com
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reproduction in any medium, provided the orfunction and absorption of gas (oxygen) from alveoli be-
hind closed or intermittently closed airways [2,3]. Venti-
lation for only a few minutes with 100% oxygen causes a
significant increase in atelectasis shortly after anesthesia
induction compared to ventilation with lower oxygen
concentration [4]. However, no clear association between
atelectasis formation and oxygen concentration during
maintenance of anesthesia has yet been established [3],
and a number of other harms and benefits still need fur-
ther investigation [5].
A FiO2 of 0.80 during and for the first few h after
elective colorectal surgery has been associated with aLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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been investigated in thirty patients how this high oxygen
concentration for a prolonged time affects postoperative
pulmonary function compared to a FiO2 of 0.30 [8].
That study found no significant changes in forced vital
capacity (FVC), forced expiratory volume (FEV1.0), arter-
ial oxygen tension (PaO2), alveolar-arterial oxygen differ-
ence ((Aa)DO2) or frequency and severity of atelectasis
as measured first postoperative day. Atelectasis deter-
mined by computed tomography (CT) was seen in 94%
of the patients given 0.80 FiO2 compared to 64% of
patients given 0.30 FiO2 (P= 0.12).
Atelectasis causes a reduction in gas exchange cap-
acity, and this can be estimated by measuring the func-
tional residual capacity (FRC) [9]. Atelectasis leads to
intrapulmonary right to left shunts [10], which can be
assessed by a decrease in the ratio between the arterial
oxygen tension and the inspired oxygen concentration,
the oxygenation index (PaO2/FiO2) [11]. An increase in
PaO2/FiO2 was found in patients given 0.40 FiO2 com-
pared to patients given 1.0 FiO2 during laparoscopic
cholecystectomy [12]. However, the perioperative
changes in PaO2/FiO2 and the FRC have not yet been
investigated in patients given 0.80 FiO2 or 0.30 FiO2.
The aim of this study was to compare the changes in
perioperative PaO2/FiO2 and FRC in patients given 0.80
FiO2 or 0.30 FiO2 during and for 2 h after surgery for
ovarian cancer. We hypothesized that a FiO2 of 0.80
would result in a larger reduction in PaO2/FiO2 at the
end of anesthesia than a FiO2 of 0.30.
Methods
Danish Medicines Agency and Local Ethics Committee
approved the study (NCT00637936), and a written
informed consent was obtained from all subjects.
The study was conducted from March 2008 to July
2008. Eligible patients were aged 18 years or older,
scheduled for explorative laparotomy for ovarian cancer,
defined as a Risk of Malignancy Index (RMI)≥ 200 [13].
Exclusion criteria were: inability to give informed con-
sent, inability to keep arterial oxygen saturation (SpO2)
above 90% without supplemental oxygen, chemotherapy
within 3 months, and surgery within 30 days (except
surgery under local anesthesia or dilation and curettage
under general anaesthesia). The study was a part of a
multicenter trial investigating the influence of FiO2 on
surgical site infection, the PROXI-trial [14,15]. However,
all patients in this study were recruited in one centre.
Patients were randomized by a central interactive
voice-response system at the Copenhagen Trial Unit to
either FiO2 = 0.30 (30%-group) or FiO2 = 0.80 (80%-
group) with stratification for center, diabetes mellitus,
acute or elective surgery and body mass index (< 30 kg/m2
vs. ≥ 30 kg/m2).All patients received paracetamol 1 g and diclofenac
50 mg orally preoperatively and pain intensity was moni-
tored in the postanesthesia care unit using the Visual
Analog Scale (VAS, scale 0–100). Analgesics were admi-
nistered if VAS exceeded 30 using opioids, non-steroid
anti-inflammatory drugs or local anesthesia epidurally if
applicable.
Patients were preoxygenated with 100% oxygen for
5 min. Anesthesia was induced with intravenous (IV) ad-
ministration of propofol 2 mg/kg together with fentanyl
or remifentanil, and rocuronium 0.6 mg/kg was given to
facilitate endotracheal intubation. Anesthesia was main-
tained with propofol or sevoflurane, and remifentanil.
After intubation, the lungs were ventilated with an
adjusted fraction of inspired oxygen of 1.0 for 5 min
until the first arterial blood sample was obtained. Subse-
quently, they received the allocated FiO2 until immedi-
ately before extubation, when an adjusted fraction of
inspired oxygen of 1.0 was given.
The level of positive end-expiratory pressure (PEEP)
was kept at 5 cmH2O. The lungs were ventilated by vol-
ume control ventilation with a tidal volume of 8–10 mL/kg
and a respiratory frequency of 10–12 per min, aiming
at an end-tidal carbon dioxide concentration of 4.5 to
6.0 kPa.
Fluid was given only to replace measured or calculated
deficits (no third space loss) aiming at a body weight in-
crease less than 1 kg [14]. Peroperative blood loss was
replaced 1:1 with colloids, not exceeding 500 mL more
than estimated blood loss [14]. Ephedrine, metaoxedrine
or dopamine-infusion was used to keep the systolic arterial
pressure> 90 mmHg. PEEP was primarily increased, if
hypoxaemia was detected or suspected in order to keep
the SpO2 above 94% and the PaO2 above 9 kPa. If this did
not improve oxygenation, FiO2 was increased. Lung re-
cruitment manoeuvres were not allowed in the period
from preoxygenation to 2 h after extubation. Neuromus-
cular block was assessed in all patients using train-of-four
(TOF) monitoring with the TOF-watchW (Danmeter APS,
Odense, Denmark). Patients were extubated, when they
were fully awake and TOF-ratio≥ 0.90.
After arrival to the postanesthesia care unit, patients
were given the allocated FiO2 for 2 h by a non-rebreathing
facemask with a reservoir (High Concentration Oxygen
Mask, Intersurgical Ltd, Wokingham, UK). Patients in the
30%-group were given a mixture of 2 litres of oxygen and
14 litres of air per minute and patients in the 80%-group
were given a mixture of 14 litres of oxygen and 2 litres of
air per minute. Subsequently, oxygen was given only at the
physician’s discretion according to usual clinical practice,
which in our institution will be to administer supplemen-
tal oxygen to keep SpO2 above 94% in a lung-healthy pa-
tient. The physician was blinded to group-allocation.
Patients were monitored with continous pulse oximetry
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nesthesia care unit.
Arterial blood samples were obtained with 2-mL syr-
inges containing heparin from a radial arterial catheter,
transported in iced water and analysed with ABL System
777 blood gas analyser (Radiometer, Copenhagen, Den-
mark) within 10 min. Samples were obtained: five min
after intubation, every half h during surgery, and 90 min
after extubation. Five samples were drawn at each meas-
urement and PaO2 was calculated as the average of three
values after omitting the highest and the lowest values.
FRC was measured the day before surgery and 2 hours
after extubation using the inert gas-rebreathing method
and the Innocor-system (Innovision, Copenhagen, Den-
mark) [16,17]. The Innocor-system measured the change
in the concentration of SF6 after 30 sec of rebreathing
with the patient in the supine position and the upper
body elevated 45°. The test was repeated and FRC calcu-
lated as the average of the two measurements. The qual-
ity of the data was evaluated on the basis of predefined
criteria [18,19] by an investigator blinded to allocation
and if of inadequate quality, they were excluded from
further analysis.
Patients were seen daily by a study investigator, and
were examined according to routine clinical practice by
the attending physician, if she presented with symptoms
of pulmonary complications, including chest radiographs
or CT, when relevant. The radiologist was specifically
instructed to evaluate the severity of atelectasis with
Joyce et al. modification [20] of Wilcox severity scoring
[21]: 0 = no atelectasis; 1 = plate atelectasis; 2 = segmental
atelectasis; 3 = partial lobar atelectasis; 4 = complete atel-
ectasis of one lung lobe; and 5 = complete atelectasis of
one lung lobe in addition to any of the above.
To maintain blinding perioperative FiO2, flow of oxy-
gen and air and PaO2 were collected on separate sheets
and placed in sealed, opaque envelopes until data ana-
lysis. The patients, surgical staff, the radiologists and the
specialist, who evaluated the FRC data, were not
informed about group allocation.
The primary outcome was the change in PaO2/FiO2 at
end of anesthesia. The secondary outcomes were change
in PaO2/FiO2 90 min after extubation, change in FRC
2 h after extubation, incidence and severity of atelectasis
within 14 days, and SpO2 2 h and 3 days after surgery.
Major violations to the protocol were defined as: lung
recruitment manoeuvre, FiO2 above 0.60 in the 30%-
group, PEEP ≥ 10 cmH2O for more than 1 h, and failure
to use the oxygen mask for more than 1 h.
Statistics
Data are reported with mean±SD or median [interquartile
range]. Data were compared with the Mann–Whitney test
and categorical data with the χ2 test using SAS forWindows, version 9.1 (SAS Institute Inc., Cary, NC, USA).
P< 0.05 was considered statistically significant.
We considered a 4 kPa difference in PaO2/FiO2 to be
clinically relevant and estimated a SD of 4 kPa based on
data from a previous study [12]. We calculated that a
total sample size of 30 patients would allow us to detect
this difference with a power of 80% and a significant
level of 0.05.
Results
We included 35 patients in this study (Figure 1, Table 1).
Five min after intubation, the median PaO2/FiO2 was
69 kPa [53-71] in the 30%-group and 60 kPa [47-69] in
the 80%-group (P= 0.25). At end of anesthesia, the
PaO2/FiO2 was 58 kPa [40-70] vs. 57 kPa [46-67] in the
30%- and 80%-group, respectively (P= 0.10, Table 2).
Ninety min after extubation, the PaO2/FiO2 was reduced
to 56 kPa [37-60] in the 30%-group and 50 kPa [42-57]
in the 80%-group (P= 0.66).
Data on FRC with adequate quality were collected in
20 patients (Figure 1). The median FRC were 1993 mL
[1610-2240] vs. 1875 mL [1545-2048] at baseline and
1615 mL [1375-2318] vs. 1633 mL [1343-1948] post-
operatively in the 30%- and 80%-group, respectively
(P= 0.70) (Table 2, Figure 2).
Changes in PaO2/FiO2 and FRC are reported in Table 3.
No significant difference was found between the groups.
Five patients (25%) in the 80%-group developed radio-
logically verified atelectasis compared to 2 patients
(13%) in the 30%-group (P= 0.51), and there were no
significant differences in postoperative SpO2 (Table 2).
Three patients had major protocol violations (Figure 1),
but the exclusion of these patients did not change the
results significantly (Table 3). In order to keep PaO2
above 9 kPa additionally one patient in the 30%-group
received 58% oxygen for one hour and one patient in the
80%-group had PEEP adjusted to 7 cmH2O. In the post-
anesthesia care unit one patient in the 30%-group was
given the allocated mixture of 2 litres of oxygen and 14
litres of air per minute until the last arterial blood sam-
ple had been drawn. Thereafter, the patient received a
mixture of 4 litres of oxygen and 12 litres of air per mi-
nute until measurement of FRC and SpO2. SpO2 was
measured with the patient breathing air.
A post hoc analysis of the alveolar-arteriel oxygen dif-
ference (AaO2 gradient) showed no significant baseline
difference between the two groups. Mean AaO2 gradient
5 min after intubation was 31 ± 16 kPa in the 80%-group
and 27 ± 15 kPa in the 30%-group (P= 0.31).
Discussion
Contrary to our primary hypothesis, we did not find a sig-
nificant difference in PaO2/FiO2 at end of anesthesia be-
tween patients given a high perioperative oxygen fraction
Figure 1 Flow chart of patients undergoing surgery for ovarian cancer. * Data quality evaluated as inadequate on the basis of predefined
criteria by an investigator blinded to allocation [18,19].
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difference in FRC or in the calculated changes.
The accuracy of the measurements was high because
five blood samples were obtained in rapid succession at
each PaO2 measurement and at established FiO2-levels
[22]. Moreover, FRC were calculated as an average of
two measurements both pre- and postoperatively and
only data of adequate quality were included.
Although we used stratified randomization, some
baseline characteristics showed a trend towards imbal-
ance. The 80%-group seemed to be at higher risk of pul-
monary complications based on age, body mass index,amount of ascites, and the proportions of previous smo-
kers and cardiovascular diseases [23-25]. However, there
was no significant difference in baseline value of PaO2/
FiO2 or AaO2 gradient between the two groups. It is a
possible limitation that removal of ascites could result in
an improvement of PaO2/FiO2 and FRC, but we found a
similar change in pulmonary function in the five patients
(all in the 80%-group) with more than 3000 mL of asci-
tes as we found in the remaining patients.
We used the body mass index to assess obesity status,
but a detailed evaluation of body fat distribution
(e.g. waist-to-hip ratio) might be a more accurate predictor
Table 1 Demographic and perioperative characteristics
for 35 patients undergoing surgery for ovarian cancer
FiO2 = 0.30 FiO2 = 0.80
(n = 15) (n = 20)
Age (years) 59 ± 16 64 ± 13
Body mass index (kg/m2) 23 ± 4 27 ± 8
Body weight (kg) 66 ± 15 72 ± 19
Smoking status
Previous smoker 1 (8%) 3 (17%)
Current smoker 5 (33%) 6 (30%)
ASA physical status I/II/III 5/8/2 4/12/4
Co-existing diseases
Hypertension 6 (40%) 12 (60%)
Other cardiovascular disease 1 (7%) 5 (25%)
Respiratory disease 1 (7%) 1 (5%)
Preoperative hemoglobin (mmol/l)
7.8 ± 0.7 7.6 ± 0.7
Amount of ascites
< 50 mL 9 (60%) 13 (65%)
50-999 mL 3 (20%) 1 (5%)
1000-2999 mL 3 (20%) 1 (5%)
≥ 3000 mL 0 - 5 (25%)
Epidural analgesia 14 (93%) 14 (70%)
Morphine dose (mg)* 5 [0–10] 0 [0–6]
Duration of FIO2 = 1.0 (min) 14 [13–16] 15 [13–17]
Duration of anesthesia (min) 179 [140–282] 154 [118–256]
Blood loss (mL) 600 [355–1200] 575 [75–1385]
Crystalloid infused (mL) 2000 [1220–2500] 1735 [1160–3500]
Colloid infused (mL) 500 [0–1000] 500 [500–1020]
Patients receiving blood 6 (40%) 5 (25%)
Units of blood transfused 2 ± 1 4 ± 2
Ephedrine dose (mg) 30 [0–30] 30 [10–48]
Other vasopressors 7 (47%) 8 (40%)
The data are presented as mean ± SD, number of patients (percentage) or
median [interquartile range].
FiO2 = inspired oxygen fraction; ASA =American Society of Anesthesiologists.
* Total morphine dose received 2 h postoperatively, including equivalent
doses of fentanyl.
Table 2 Pulmonary function in 35 patients undergoing
surgery for ovarian cancer
FiO2 = 0.30 FiO2 = 0.80 P value
(n = 15) (n = 20)
PaO2/FiO2 (kPa)
5 min after intubation * 69 [53–71] 60 [47–69] 0.25
30 min after intubation 58 [37–72] 58 [44–67] 0.39
End of anesthesia 58 [40–70] 57 [46–67] 0.10
90 min after extubation 56 [37–60] 50 [42–57] 0.66
FRC (mL) #
Preoperative 1993 [1610–2240]1875 [1545–2048]
2 h after extubation 1615 [1375–2318]1633 [1343–1948] 0.70
Arterial oxygen saturation
Preoperative (%) } 97 ± 2 96 ± 2
≤ 95% 2 h after extubation } 3 (20%) 6 (33%) 0.50
≤ 95% 3 days after surgery } 2 (13%) 7 (35%) 0.15
Atelectasis {
No atelectasis 13 (87%) 15 (75%) 0.51
Plate atelectasis 0 0
Segmental atelectasis 1 (7%) 0
Partial lobar atelectasis 0 0
Complete atelectasis of one
lung lobe 0 2 (10%)
Complete atelectasis of one
lung lobe in addition
to any of
the above 1 (7%) 3 (15%)
The data are presented as mean ± SD, number of patients (percentage) or
median [interquartile range].
P values are calculated by Mann–Whitney test to compare the changes from
baseline values between the two groups.
PaO2 = arterial oxygen tension; FiO2 = inspired oxygen fraction; PaO2/
FiO2 = oxygenation index;
FRC = functional residual capacity.
* Measured at FiO2 =1.0.
# Preoperative data were missing in 9 patients. Postoperative data were
missing in 15 patients (Figure 1).
} Measured with the patient breathing room air.
{ Severity of atelectasis assessed according to Joyce et al. modification [20] of
Wilcox severity scoring [21].
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index is easier to determine and is consistent with most of
the previous studies evaluating perioperative FiO2.
All patients were preoxygenated with 100% oxygen
and received 100% oxygen just before extubation. Com-
pletely avoiding a high FiO2 in the 30%-group would
have been an advantage regarding atelectasis formation,
but a lower FiO2 than 1.0 during preoxygenation and
immediately prior to tracheal extubation is generally not
recommended, because it reduces the margin of safetysignificantly [4], considering the risk of difficult airway
management. In this study, ventilation with 100% oxygen
after intubation was additionally used for a relatively
long period in order to ensure baseline equilibrium of
PaO2 and FiO2. This method of increasing baseline reli-
ability may on the other hand have contributed to fur-
ther atelectasis formation [4]. It is possible that the
amount of atelectasis was similar in both groups imme-
diately after preoxygenation and induction of anesthesia
and remained unchanged hereafter irrespective of the
subsequent FiO2, which is a potential limitation of this
study [4].
FiO2 = 0.30 FiO2 = 0.80
Figure 2 Mean changes in functional residual capacity (FRC) in 35 patients undergoing surgery for ovarian cancer. Solid line represents
the group’s mean. FiO2 = inspired oxygen fraction. Data were missing in 15 patients because of instrumental failure (5 and 3 patients in the 30%-
and 80%-group, respectively), inadequate data quality (2 and 3 patients) and 2 patients in the 80%-group refused the postoperative test
(Figure 1).
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ment to quantify the amount of impaired gas exchange.
It is affected by numerous factors other than true intra-
pulmonary right to left shunts caused by atelectasis,
such as changes in circulatory blood volume, vasopres-
sor use, positioning of the patient and body temperature.
These factors were, however, not different between the
groups. Other factors such as ventilation-perfusion (VA/
Q) inequality and hypoxic pulmonary vasoconstriction
can also have modified the PaO2/FiO2. Moreover the
PaO2/FiO2 is not linearly correlated to FiO2 [22,27]. As
outcome we measured the change in the PaO2/FiO2
from samples drawn at two different FiO2-levels in each
patient: baseline at FiO2 1.0 and endpoints at FiO2 0.3
or 0.8. However, the mean difference between the groups
in PaO2/FiO2 change from 30 min after intubation to
the end of anesthesia (measured at the same FiO2-level
in each group) was only 3.0 kPa (P= 0.39). We therefore
consider it most likely that any difference in PaO2/FiO2
must be related to the induction of anesthesia including
the change from 1.0 to the allocated FiO2.
The FRC measurements required patients to breathe
deeply for 30 sec with a respiratory frequency of 20 per
min. The 7 patients (5 in the 80%-group) who wereTable 3 Changes in pulmonary function in 35 patients underg
Change in PaO2/FiO2 at the end of anesthesia (kPa
FiO2 = 0.30 FiO2 = 0.80
(n = 15) (n = 20)
Intention-to-treat −7.5 ± 10 -1.2 ± 10
n= 13 n= 20
Per-protocol * −7.1 ± 9 -1.2 ± 10
The data are mean difference form baseline ± SD. P values are calculated by Mann–
groups. PaO2 = arterial oxygen tension; FiO2 = inspired oxygen fraction; PaO2/FiO2 =
* Excluded patients are described in Figure 1.unable to cooperate sufficiently or declined to perform
the test, had a longer duration of anesthesia, a larger
blood loss, and also a larger reduction in PaO2/FiO2.
Thus, an effect of high FiO2 on the change in FRC could
have been overlooked, because FRC data in these
patients were missing. The need for cooperation is a dis-
advantage of the inert gas-rebreathing method in the
clinical setting even though it can be very useful in
healthy individuals or mechanically ventilated patients.
The mean difference in PaO2/FiO2 reduction between
the 30%-group and the 80%-group was 6.3 ± 10 kPa. There-
fore, we cannot exclude that a clinically important differ-
ence exists, but our SD was larger than expected and it
would require almost 200 patients to detect this difference.
The application of PEEP=5 cmH2O may have reduced
the amount of intraoperative atelectasis and improved the
oxygenation [28], however PEEP was applied equally to all
patients exept for 1 in the 30%-group. Hedenstierna et al.
showed in a study of 12 patients a trend towards reoccur-
ence of atelectasis within 5 min after discontinuation of
PEEP [29] In contrast, a Cochrane review from 2010 indi-
cated that intraoperative PEEP of 5–10 cm H2O may re-
duce postoperative atelectasis and improve postoperative
gasexchange (PaO2/FiO2) [30].oing surgery for ovarian cancer.
) Change in FRC 2 h after extubation (mL)
P value FiO2 = 0.30 FiO2 = 0.80 P value
(n = 8) (N = 12)
0.10 -49 ± 507 −152± 382 0.70
n = 7 n= 12
0.10 60 ± 435 −152± 382 0.35
Whitney test to compare the changes from baseline values between the two
oxygenation index; FRC = functional residual capacitity.
Staehr et al. BMC Research Notes 2012, 5:383 Page 7 of 8
http://www.biomedcentral.com/1756-0500/5/383We found a mean reduction in FRC of 8%, and this is
less than the 20% reduction measured shortly after intub-
ation [31], but in accordance with the 12% reduction
found on the first day after lower abdominal surgery [32].
A postoperative reduction in FRC may not solely be
caused by collapse of some lung units (atelectasis), but
also by a general change in intrathoracic volumes caused
by reflex diaphragmatic dysfunction, shallow breathing,
mechanical disruption of the abdomen, pulmonary
edema, increased abdominal blood volume or postopera-
tive incisional pain[32,33]. We found that the change in
FRC and in postoperative PaO2/FiO2 tended to be larger
in the patients, who did not receive thoracic epidural an-
algesia and this was the case for 6 of the 20 patients in
the 80%-group and 1 of the 15 patients in the 30%-
group. However, none of these patients developed radio-
logically verified atelectasis. Epidural analgesia improves
some aspects of pulmonary function, which may be
attributed to better pain control [34]. We used standar-
dized pain relief to ensure that all patients had adequate
analgesia even if epidural was not used. We found no
significant difference in overall opiod consumption be-
tween the groups (Table 1).
Our observed changes in FRC may have been too
small to affect the PaO2/FiO2 as noted by Dueck et al.
[35]. Their study showed only a small effect of FRC re-
duction on the degree of pulmonary shunt until FRC/
TLC was less than 0.30, i.e. less than awake, supine clos-
ing capacity.
Akca et al. found no significant difference in incidence
of atelectasis assessed by CT (64% vs. 94%; P= 0.12) in
patients given 30% or 80% oxygen, respectively [8]. Such
high incidences are related to the high sensitivity of a
CT-scan. In our study, seven patients (20%) developed
radiological verified atelectasis in addition to pulmonary
symptoms. With this definition of atelectasis, no signifi-
cant difference in atelectasis was found among the 1,400
patients included in the PROXI-trial (7.9% vs. 7.1% in
the 80% and 30% oxygen group, respectively (P= 0.60))
[15]. Edmark et al. showed that the benefit of using 80%
oxygen compared to 100% oxygen during induction of
anesthesia in order to reduce atelectasis diminished
gradually with time [36]. These results may indicate that
other factors than the oxygen concentration are import-
ant to the formation of late peroperative atelectasis.
Moreover, patients who are treated with hyperbaric oxy-
gen usually receive oxygen at a pressure of 240 kPa in 3
cycles of 30 min show no clinically significant signs of
reduction in pulmonary function [37]. This is in accord-
ance with the results found in our study
The patients included were middle-aged women,
undergoing explorative laparotomy of a substantial dur-
ation. We cannot reject the possibility that 80% oxygen
for a prolonged period may affect PaO2/FiO2 and FRCmore in heavy smokers or among patients with severe
pulmonary or cardiovascular comorbidity.
Conclusion
Ventilation with 80% oxygen for several hours was not
significantly associated with changes in the perioperative
oxygenation index or functional residual capacity com-
pared to ventilation with 30% oxygen. However, a larger
trial is required to exclude that an important difference
in oxygenation or other clinical outcomes exists.
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